Detection of the Soluble Fas Receptor Level in Sera from Patients with Myelodysplastic Syndrome and Acute Leukemia and Its Significance / 中国肿瘤生物治疗杂志

To detect the soluble Fas (sFas) receptor level in sera from patients with myelodysplastic syndrome (MDS) and acute leukemia (AL), and investigate its clinical significance, the levels of sFas receptor in sera from 18 patients with MDS and 42 patients with AL were detected by using ELISA methods. The results suggested that the sFas receptor levels in sera from patients with MDS-RA were significantly lower than that from normal control (2.89?1.72 ng/ml vs 6.29?1.07 ng/ml, P

The serum levels of soluble Fas ligand and soluble Fas receptor in patients with chronic congestive heart failure / 重庆医科大学学报

0. 05 ]. However, the level of sFas was significantly higher in the patients with CHF than those of the cardiac function class Ⅰ group [CHF group: 1353. 30 ? 507. 71 (cardiac function class Ⅱ 1154. 85 ? 371.20, class Ⅲ 1412. 88 ? 493. 62, class Ⅳ 1875.67 ? 806. 10) vs. cardiac function class Ⅰ group:983. 11 ? 416.26 pg/ml, P